FCPM III SERVICES B.V.: 13F holdings
CIK 20134102026Q2
| Positions | 11 |
|---|
| Reported value | $750.4m |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 11 (+1 vs prior quarter) |
|---|
| Reported value | $750.4m (+3.9%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| NEWAMSTERDAM PHARMA COMPANY | 8,490,353 | $287.7m | 38.3% |
| MAPLIGHT THERAPEUTICS INC | 3,226,400 | $115.6m | 15.4% |
| DYN DYNE THERAPEUTICS INC | 3,848,256 | $85.5m | 11.4% |
| VOR VOR BIOPHARMA INC | 4,117,354 | $75.8m | 10.1% |
| DAMORA THERAPEUTICS INC | 2,441,000 | $63.5m | 8.5% |
| REPL REPLIMUNE GROUP INC | 2,808,368 | $31.1m | 4.1% |
| CRESCENT BIOPHARMA INC. | 1,677,852 | $30.2m | 4.0% |
| AURA AURA BIOSCIENCES INC | 4,053,775 | $28.8m | 3.8% |
| ENGENE HOLDINGS INC | 9,632,561 | $16.7m | 2.2% |
| BCYC BICYCLE THERAPEUTICS PLC | 3,468,430 | $14.7m | 2.0% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="2013410")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples